Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi To Cut Drug Prices In South East Asia In Experiment Aimed At Creating A Sustainable Model Of Access

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Sanofi-Aventis hopes to widen the availability of its medicines in less developed nations by slashing the price of some drugs in Southeast Asia, in a move that could be modeled after a similar program launched by GlaxoSmithKline one year ago

You may also be interested in...



Graham Almond On Sanofi’s Plans to Build Zentiva Generics Brand In Southeast Asia: An Interview With PharmAsia News (Part 1 of 2)

PharmAsia News talks with Sanofi Vice President Southeast Asia, Global Operations Graham Almond to see how the company, with a long-standing presence in the region, is dealing with expansions in public health care coverage to grow its generics business.

New Wave Of Cancer Drugs Puts Hard Focus On Need For Inexpensive Screening

Stunning advances in cancer therapies have sharpened the need for low-cost gene sequencing to identify the right patients for the right drugs, especially in Asia, frontline cancer experts say.

New Wave Of Cancer Drugs Puts Hard Focus On Need For Inexpensive Screening

Stunning advances in cancer therapies have sharpened the need for low-cost gene sequencing to identify the right patients for the right drugs, especially in Asia, frontline cancer experts say.

Related Content

UsernamePublicRestriction

Register

OM014142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel